Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-16
1997-02-25
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514544, 560 70, 549406, A61K 3135, C07D31104
Patent
active
056059299
ABSTRACT:
Disclosed are a novel class of antiandrogenic compounds including saturated and unsaturated fatty acids, catechin gallates, their derivatives, and synthetic analogs, their method of synthesis, and their use in treating disorders associated with androgenic activities. Also disclosed is the use of known compounds not previously known for their antiandrogenic activity in treating disorders related to androgenic activities and cancers.
REFERENCES:
patent: 4191759 (1980-03-01), Johnston et al.
patent: 4220775 (1980-09-01), Rasmusson et al.
patent: 4268517 (1981-05-01), Niebes et al.
patent: 4394389 (1983-07-01), Van't Riet et al.
patent: 4840966 (1989-06-01), Hara et al.
patent: 5032514 (1991-07-01), Anderson et al.
patent: 5126129 (1992-06-01), Wiltrout et al.
patent: 5318986 (1994-06-01), Hara et al.
Hashimoto et al. Chem. Pharm. Bull. (Japan) 37(1), 77-85, 1989 (English).
Anderson and Liao, Nature 219:277, (1968).
Baba, et al., J. Neurochem. 42:192 (1984).
Beato, Cell 56:335 (1989).
Begin, Proc. Nutrition Soc. 49:261-267 (1990).
Bingham and Shaw, J. Endocr. 57:111 (1973).
Bjorneboe, et al., Brit. J. Dermatol. 118:77-83 (1988).
Blohm et al., Endocrinology 119:959 (1986).
Blohm et al., Biochem. Biophy. Res. Comun. 95:273 (1989).
Bradnt, et al., J. Steroid Biochem Mol. Biol. 37:575 (1990).
Bruchovsky and Wilson, J. Biol. Chem. 243:2012 (1968).
Brooks, et al., Proc. Soc. Esp. Biol. Med. 169:67 (1982).
Brooks, et al., Endocrinology 109:830 (1981).
Brooks, et al., The Prostate 3:35 (1982).
Carter and Coffrey, The Prostate 16:39-48 (1990).
Chang and Liao, J. Steroid Biochem. 27:123 (1987).
Cooke and Robaire, J. Biol. Chem. 260:7489 (1985).
Cusan, et al., J. Am. Acad. Dermatol. 23:462-469 (1990).
Dell and Severson, Biochem. J. 258:171 (1989).
Diani et al., J. Clin. Endocr. and Metabl. 74:345 (1992).
Dinadiao, May Clin. Proc. 66:1018-1028 (1991).
Downing, et al., J. Am. Acad. Dermo. 14:221-225 (1986).
Ehrmann and Rosenfield, J. Clin. Endocrinol. Metab. 71:1 (1990).
Evans, Science 240:889 (1989).
Fang and Liao, Mol. Pharmacol. 5:428 (1969).
Frost and Gomez, Adv. Biol. Skin. 12:403 (1972).
Gent and ho, Biochemistry 17:3023 (1978).
Gent, et al., J. Biophys. 33:211 (1981).
George, et al., Endocrinology 119:959 (1989).
Gershon and Parmegiani, J. Med. Chem. 10:186 (1967).
Gittes, New England J. Med. 324:236 (1991).
Gormley, et al., J. Clin. Endocrinol. Metab. 70:1136 (1990).
Gorski, et al., Ann. Rev. Physiol. 42:17 (1976).
Halquenset, et al., J. Steroid Biochem. 28:731 (1983).
Hall, New Phytol. 71:855 (1972).
Hamilton, Am. J. Anat. 71:451 (1942).
Hammerstein, et al., J. Steroid Biochem. 19:591 (1983).
Hebborn, et al., Arch Dermatol. 124:387-391 (1988).
Herold and Kinsella, Am. J. Clin. Nutr. 43:566 (1986).
Hiipakka, et al., Endocrine Dependent Tumors, ed. Voight & Knabbe 2:43-61 (1991).
Horrobin, et al., J. Am. Acad. Dermatol. J. Am. Acad. Dermatol. 20:1045-53 (1989).
Horszewicz, et al., Cancer Res. 43:1809 (1983).
Huggins and Hodges, Cancer Res. 1:293 (1940).
Ichihara and Tanaka, Biochem. Biophys. Res. Comm. 149:481 (1981).
Imperato-McGinley, Trend Genet. 2:134 (1986).
Imperato-McGinley et al., J. Clin. Endocr. Metab. 70:77 (1990).
Isaacs, J. Clin. Endocr. Metab. 56:139 (1983).
Jensen, et al., Proc. Nat'l Acad. Sci. (USA) 59:632 (1968).
Kaighn, et al., Invest. Urol. 17:16 (1979).
Karmali, et al., J. Nat'l Cancer Inst. 73:457 (1984).
Kato, J. Steroid Biochem. 34:219 (1989).
Khan, 35 al., Febs Letter 292:98 (1991).
Kwok, et al., J. Am. Chem. Soc. 109:3684 (1987).
Lands, Ann. Rev. Biochem. 34:313 (1965).
Liang, et al., Endocrinology 112:1460 (1983).
Liang, et al., Endocrinology 115:2311 (1984).
Liang and Heiss, J. Biol. Chem. 256:7998 (1981).
Liang, et al., J. Steroid Chem. 19:385 (1983).
Liang and Liao, Clin. Research 39:720A.
Liao and Fang, Vitamins and Hormones 27:17 (1974).
Liao, et al., Endocrinology 94:1205 (1974).
Liao, et al., J. Biol. Chem. 248:6154 (1973).
Liao, Int. Rev. Cytology 41:87 (1975).
Liao, et al., J. Steroid Biochem. 34:41-51 (1989).
Mock, et al., J. Pediatrics 106:762 (1985).
Moguilewsky and Bouton, J. Steroid Biochem. 31:699 (1988).
Mooradian et al., Endocrine Rev. 8:1 (1987).
Morello, et al., Invest. Derm. 66:319 (1976).
Morse, et al., Brit. J. Dermatol. (1989) 121:75-90.
Munnich, et al., Lancet 2:1080 (1980).
Nalboone, et al., Lipids 25:301 (1990).
Needleman, et al., Ann. Rev. Biochem. 55:69 (1986).
Newman, Proc. Nat'l Acad. Sci. 87:5543-5547 (1990).
O'Malley, Mol. Endocrinol. 4:363 (1990).
Pattison and Buchanan, Biochem. J. 92:100 (1964).
Phillipson, et al., Eng. J. Med. 312-1210 (1985).
Pochi, Ann. Rev. Med. 41:187 (1990).
Rasmusson, et al., J. Med. Chem. 29:2298 (1986).
Rittmaster, et al., J. Androl. 10:259 (1989).
Rittmaster, et al., J. Clin. Endocr. Metab. 65:188-193 (1987).
Rose and Connolly, The Prostate 18:243-254 (1991).
Sansone and Reisner, J. Invest. Dermatol. 56:366 (1971).
Schafer and Kragballe, Lipids 26:557-560 (1991).
Schweikert and Wilson, Clin. Endocrinol. Metab. 38:811 (1974).
Serafini and Lobo, Fert. Steril. 43:74 (1985).
Siiteri and Wilson, J. Clinical Invest. 49:1737 (1970).
Strauss and Yesalis, Ann. Rev. Med. 42:499 (1991).
Strong, et al., Brit. J. Clin. Prac. Nov/Dec:444-445 (1985).
Synder, Ann. Rev. MEd. 35:207 (1984).
Szepesi, et al., J. Nutr. 119:161 (1989).
Tesoriere et al., J. Neurochem. 51:704 (1988).
Tosaki and Hearse, Basic Res. Cardiol. 83:158 (1988).
Vallette, et al., J. Steroid Biochem. 263:3639 (1988).
Vermeulen et al., The Prostate 14:45 (1989).
Voigt, et al., J. Biol. Chem. 248:4248 (1973).
Wenderoth and George, Endocrinology, 113:569 (1983).
Wilson, Am. J. Med. 68:745 (1980).
Wright, Prostaglandins, Leukotrienes and Essential Fatty Acids 38:229 (1989).
Ziboh and Miller, Ann. Rev. Nutr. 10:433 (1990).
Ziboh, ARch Dermatol. 125:241-245 (1989).
Zuniga, et al., J. Nutr. 119:152 (1989).
Begin, et al., NJCI, 5:1053-1061 (1986).
Anderson, et al., Prostaglandins, Leukotrienes and Essential Fatty Acids, 40:137-141 (1990).
Liang, et al., J. Biol. Chem. 260:4890-4895 (1985).
International Search Report, PCT/US93/04090.
Andersson and Russell, "Structural and biochemical properties of cloned and expressed human and rat steroid 5.alpha.-reductases," Proc. Natl. Acad. Sci. USA, 87:3640-3644, May, 1990.
Andersson et al., "Deletion of steroid 5.alpha.-reductase 2 gene in male pseudohermaphroditism," Nature, 354:159-161, Nov. 1991.
Andersson et al., "Expression Cloning and Regulation of Steroid 5.alpha.-Reductase, an Enzyme Essential for Male Sexual Differentiation, " J. Biol. Chem., 264(27):16249-16255, Sep. 1989.
Berman and Rusell, "Cell-type-specific expression of rat steroid 5.alpha.-reductase isozymes," Proc. Natl. Acad. Sci. USA, 90:9359-9363, Oct. 1993.
Faller et al., "Finasteride: A Slow-Binding 5.alpha.-Reductase Inhibitor," Biochemistry, 32:5705-5710, 1993.
Giovannucci, "Epidemiologic Characteristics of Prostate Cancer," Cancer (Suppl.), 75(7):1766-1777, Apr. 1995.
Harris et al., "Identification and selective inhibition of an isozyme of steroid 5.alpha.-reductase in human scalp," Proc. Natl. Acad. Sci. USA, 89:10787-10791, Nov. 1992.
Hilpakka and Liao, "Androgen Receptors and Action," Endocrinology, 3rd ed., (DeGroot, L. I., ed.) W. B. Saunders Co., Philadelphia, 2336-2351, 1995.
Hirsch et al., "LY191704: A selective, nonsteroidal inhibitor of human steroid 5.alpha.-reductase type 1," Proc. Natl. Acad. USA, 90:5277-5281, 1993.
Honda et al., "Inhibition of Saccharide Digestive Enzymes by Tea Polyphenols," In: Food Phytochemicals for Cancer Prevention II, ACS Symp. Ser. 547:84-89, American Chemical Society, Washington, D.C., 1994.
Liang and Liao, "Inhibition of steroid 5.alpha.-reductase by specific aliphatic unsaturated fatty acids," Biochem. J., 285:557-562, 1992.
Liang et al., "Species Differences in Prostatic Steroid 5.alpha.-Reductases of Rat, Dog and Human," Endocrinology, 117(2):571-579, 1985.
McConnell et al., "Finasteride, an Inhibitor of 5.alpha.-Reductase, Suppresses Prostatic Dihydrotestosterone in Men with Benign Prostatic Hyperplasia," Journal of Clinical Endocrinology and Metabolism, 74(3):505-508, 1992.
Moore and Pizza, "Obse
Liang Tehming
Liao Shutsung
Arch Development Corp.
Shah Mukund J.
Sripada Pavanaram K.
LandOfFree
Methods and compositions for inhibiting 5.alpha.-reductase activ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for inhibiting 5.alpha.-reductase activ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for inhibiting 5.alpha.-reductase activ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1974324